Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 1]
A Phase 1 trial evaluating a vaccine therapy for stage IIB to stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib, paclitaxel, and carboplatin in patients with metastatic and intraocular melanoma h…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma [Phase 1]
Phase 1 trial of adoptive transfer of MART1/Melan-A–specific cytotoxic T lymphocytes for malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating the combination of erlotinib and bevacizumab in patients with stage IV melanoma; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1]
Phase 1 clinical trial update on a vaccine therapy for stage IV melanoma; the study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: RAD001 Plus Bevacizumab in Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating RAD001 ( everolimus ) plus bevacizumab in metastatic melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [Phase 1]
Phase 1 trial evaluating a monoclonal antibody therapy for patients with brain tumors and melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]
A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hema…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of O6-benzylguanine and Carmustine in patients with unresectable locally recurrent or metastatic …
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial evaluating thalidomide in combination with SU5416 for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma [Phase 1]
Phase 1 clinical trial update for a vaccine therapy in unresectable metastatic melanoma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Vaccine Therapy in Treating Patients With Melanoma [Phase 1]
Phase 1 clinical trial evaluating a melanoma vaccine therapy in patients with melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Decitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 trial of decitabine in patients with advanced solid tumors, including breast, bladder, and m…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: BMS-247550 in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial of BMS-247550 in patients with stage IV (recurrent) melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated [Phase 2]
This document reports the termination of a Phase 2 trial of SU5416 (semaxanib) in patients with previously treated metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2013-01-22Clinical Trial Update: Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma [Phase 2]
Phase 2 trial evaluating chemotherapy followed by gp100 lymphocytes and aldesleukin for metastatic melanoma; the study completed and results…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma [Phase 2]
Phase 2 clinical trial evaluating temozolomide plus thalidomide for brain metastases arising from melanoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma [Phase 2]
Phase 2 trial evaluating a vaccine plus interleukin-2 for advanced melanoma has completed. The study covered recurrent and stage IV melanoma…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial assessing isolated limb infusion of chemotherapy for patients with melanoma or soft tissue sarcoma of the arm or leg that cann…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma [Phase 2]
Phase 2 clinical trial update evaluating PET and CT imaging to monitor patients with stage III or stage IV melanoma.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 trial evaluating sorafenib in patients with unresectable stage III or stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 clinical trial evaluating vaccine therapy using melanoma peptides to stimulate cytotoxic and helper T cells in metastatic melanoma; …
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Phase 1]
Phase 1 trial of cisplatin, temozolomide, Abraxane with interleukin-2 and interferon for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluated reinfusion of autologous lymphocytes during immune suppression to treat metastatic melanoma; results were posted a…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes [Phase 2]
Phase II trial evaluating lymphodepletion followed by infusion of anti-MART-1 F5 TCR-engineered T cells in metastatic melanoma has completed…